Reinventing drug discovery with the power of genomics
We use machine learning and human genomic data to accelerate the discovery of new treatments for patients with neurodegenerative diseases.
A multi-disciplinary team pioneering a new approach to drug discovery.
Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, we share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.